(Q33249813)

24 July 2017

title

EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force (English)

1 reference

24 July 2017

R Soffietti

1 reference

24 July 2017

P Cornu

1 reference

24 July 2017

J Y Delattre

1 reference

24 July 2017

R Grant

1 reference

24 July 2017

F Graus

1 reference

24 July 2017

W Grisold

1 reference

24 July 2017

J Heimans

1 reference

24 July 2017

J Hildebrand

1 reference

24 July 2017

P Hoskin

1 reference

24 July 2017

M Kalljo

1 reference

24 July 2017

P Krauseneck

1 reference

24 July 2017

C Marosi

1 reference

24 July 2017

T Siegal

1 reference

24 July 2017

C Vecht

1 reference

24 July 2017

publication date

1 July 2006

1 reference

European Journal of Neurology

24 July 2017

published in

1 reference

24 July 2017

1 reference

24 July 2017

1 reference

24 July 2017

page(s)

674-681

1 reference

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Identification of prognostic factors in patients with brain metastases: a review of 1292 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Brain metastases from unknown primary tumour: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Detection of unknown primary tumours in patients with cerebral metastases using whole-body 18F-flouorodeoxyglucose positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Effectiveness of antiepileptic prophylaxis used with supratentorial craniotomies: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Surgical resection for patients with solid brain metastases: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Stereotactic radiosurgery for patients with solid brain metastases: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Radiotherapy and chemotherapy of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Radiographic findings and morbidity in patients treated with stereotactic radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Radiation-induced dementia in patients cured of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Radiotherapy for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01506.X

10.1111/J.1468-1331.2006.01506.X

21 January 2018

Identifiers

DOI

1 reference

24 July 2017

1 reference